RWA WEALTH PARTNERS, LLCRWA WEALTH PARTNERS, LLC

Institutional investor · Portfolio as of Q2 2020

SEC EDGAR SourceSEC Filings

Top Holdings211 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

162,716$50.4M6.2%$265.73+6.16%
6 qtrssince 2019-Q1
Increased
68
VIGVIG
ETF

VANGUARD DIVIDEND APPRECIATION ETF ETF

397,004$46.5M5.7%$95.91+8.91%
6 qtrssince 2019-Q1
Decreased
0
FHLCFHLC
ETF

FIDELITY HEALTH CARE ETF

728,621$36.3M4.4%$40.95+11.21%
6 qtrssince 2019-Q1
Increased
55
414,653$34.5M4.2%
Decreased
0
EFGEFG
ETF

ISHARES MSCI EAFE GROWTH ETF

414,615$34.5M4.2%$70.27+8.31%
6 qtrssince 2019-Q1
Increased
60
VCITVCIT
ETF

VANGUARD INT-TERM CORPORATE

349,327$33.2M4.1%$67.13+12.98%
6 qtrssince 2019-Q1
Increased
54
VTEBVTEB
ETF

VANGUARD TAX-EXEMPT BOND ETF

565,442$30.6M3.7%$44.40+3.77%
6 qtrssince 2019-Q1
Increased
68

APPLE INC

65,930$24.1M2.9%$46.11+91.34%
6 qtrssince 2019-Q1
Increased
50
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

69,761$21.5M2.6%$255.16+10.47%
6 qtrssince 2019-Q1
Decreased
0
VGITVGIT
ETF

VANGUARD INTERMEDIATE-TERM T

292,559$20.6M2.5%$59.380.00%
1 qtr
New
74

MICROSOFT CORP

100,911$20.5M2.5%$113.02+67.64%
6 qtrssince 2019-Q1
Increased
50
FBNDFBND
ETF

FIDELITY MERRIMACK STR TR

341,989$18.4M2.3%$40.32+5.06%
3 qtrssince 2019-Q4
Increased
49
SHMSHM
ETF

SS SPDR N ICE ST MUNI ETF

303,531$15.1M1.9%$43.70+4.49%
6 qtrssince 2019-Q1
Decreased
0
VBKVBK
ETF

VANGUARD SMALL-CAP GRWTH ETF

75,105$15M1.8%$157.64+20.83%
6 qtrssince 2019-Q1
Increased
49
VOTVOT
ETF

VANGUARD MID-CAP GROWTH ETF

90,138$14.9M1.8%$139.85+11.90%
6 qtrssince 2019-Q1
Increased
55
FTECFTEC
ETF

FIDELITY MSCI INFO TECH ETF

139,285$11.5M1.4%$57.40+35.46%
6 qtrssince 2019-Q1
Decreased
0
LQDLQD
ETF

ISHARES IBOXX INVESTMENT GRA

75,157$10.1M1.2%$92.10+16.99%
6 qtrssince 2019-Q1
Decreased
0
VIOGVIOG
ETF

VANGUARD ADMIRAL FDS INC

69,086$10.1M1.2%$71.10-4.28%
6 qtrssince 2019-Q1
Increased
51

JOHNSON & JOHNSON

63,397$8.9M1.1%$117.42+1.35%
6 qtrssince 2019-Q1
Increased
46
IBBIBB
ETF

ISHARES BIOTECHNOLOGY ETF

64,745$8.9M1.1%$125.76+5.57%
6 qtrssince 2019-Q1
Increased
70
$818M
AUM
211
Positions
Q2 2020
Filing
Rating · 5.0
Quarterly Portfolio Change
+6%Q2'19$931.3M+2%Q3'19$946.9M+7%Q4'19$1B-30%Q1'20$705.6M+16%Q2'20$818M
Activity profile
$ moved · Q2'20
New21%Increased42%Decreased25%Exited12%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q11%1-4Q5%1-2Y84%2Y+0%

RWA WEALTH PARTNERS, LLC manages $818M across 211 positions as of Q2 2020. Top holdings: IVV (6.2%), VIG (5.7%), FHLC (4.4%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 5/5.0.

Q2 2020 Summary

Active quarter - 33 new positions, 19 exits, 92 increased. Top move: VGIT (NEW, conviction 74). Portfolio: $818M across 211 positions.

Top holdings by portfolio weight

Total AUM$818M
IVV6.16%
VIG5.69%
FHLC4.43%
VANGUARD BD 4.21%
EFG4.21%
VCIT4.06%
VTEB3.74%
AAPL2.94%
SPY2.63%
VGIT2.52%
Other2.51%

Portfolio allocation by GICS sector

Sectors11
Unknown63.13%
Technology10.54%
Healthcare6.70%
Financial Services4.63%
Communication Services3.50%
Consumer Cyclical3.47%
Industrials3.39%
Consumer Defensive2.69%
Utilities1.17%
Real Estate0.48%
Other0.31%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Elite(5.0 / 5.0)
Track Record73
Conviction42
Concentration77
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
RSPRSPINVESCO S&P 500 EQUAL WEIGHT
Q3 2024 Q2 2026+46,364 shares+$10.1M
8Q
NEARNEARISHARES U S ETF TR
Q3 2024 Q2 2026+848 shares+$45,831
8Q
NVSNVSNOVARTIS AG-SPONSORED ADR
Q3 2024 Q2 2026+3,479 shares+$1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used